跳至主要内容
临床试验/CTRI/2024/04/066334
CTRI/2024/04/066334尚未招募4 期

A randomized controlled trial to compare safety and efficacy of inhalational long acting ß2 agonist Vilanterol with fluticasone furoate against Salmeterol with fluticasone furoate in adult patients with reversible obstructive airway disease. - NI

Central Research And Publication Unit0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age: 18 – 60 years of age.
  • Clinically diagnosed patients of chronic obstructive airway disease with FEV 1 between 40% to 85% of the predicted normal value.

排除标准

  • Acute exacerbations of asthma.

研究者

发起方
Central Research And Publication Unit

相似试验